Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis - PubMed (original) (raw)
Comparative Study
. 2004 Mar 15;100(6):1110-22.
doi: 10.1002/cncr.20095.
Baocun Sun, Limei Hu, Harri Lähdesmäki, Valerie Dunmire, Yumei Feng, Shi-Wu Zhang, Huamin Wang, Chunlei Wu, Hua Wang, Gregory N Fuller, W Fraser Symmans, Ilya Shmulevich, Wei Zhang
Affiliations
- PMID: 15022276
- DOI: 10.1002/cncr.20095
Free article
Comparative Study
Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis
Xishan Hao et al. Cancer. 2004.
Free article
Abstract
Background: Metastatic disease is a major adverse prognostic factor in breast carcinoma. Lymph node metastases often represent the first step in the metastatic process.
Methods: To gain insight into the molecular events that underlie breast carcinoma metastasis, the authors compared gene expression profiles, obtained by cDNA microarray analysis, of nine matched primary tumors and metastases after screening for enrichment of tumor cells. Statistical analysis identified genes that are expressed at elevated or decreased levels in metastases relative to the corresponding primary tumors. Multidimensional scaling analysis indicated that in terms of expression levels, primary tumors were tightly clustered, whereas metastases exhibited a greater spread; this finding points to the more heterogeneous nature of metastases. Among the differentially expressed entities were the invasion- and tissue modeling-related genes IGFBP5, fibronectin, and MMP2; the cell cycle regulatory gene cyclin D1; other genes, such as enolase 2; and an expressed sequence tag similar to angiopoietin 1. To validate and extend these initial findings, the authors constructed a tissue microarray consisting of 100 primary malignancies paired with their lymph node metastases. Antibodies for the IGFBP-5, fibronectin, MMP-2, cyclin D1, and MDM-2 proteins were used to stain tissue array sections.
Results: Consistent with microarray data, statistically significant overexpression of IGFBP-5, down-regulation of cyclin D1, and unchanged MDM-2 levels were observed in metastatic tumor cells. Nonetheless, although fibronectin and MMP2 mRNA expression levels were decreased in many metastasis specimens, expression levels of the corresponding proteins in the extracellular matrix were elevated in most metastases. Decreased expression of fibronectin and MMP2 in lymph node metastases was further confirmed by real-time polymerase chain reaction assays performed on five additional specimen pairs.
Conclusions: The results of the current study suggest that extracellular matrix protein expression and nuclear gene expression are associated via a negative-feedback regulatory mechanism. Therefore, gene expression profiling and tissue array validation should be combined to elucidate molecular events associated with the metastatic process.
Copyright 2004 American Cancer Society.
Similar articles
- Differential gene and protein expression in primary gastric carcinomas and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis.
Xie HL, Li ZY, Gan RL, Li XJ, Zhang QL, Hui M, Zhou XT. Xie HL, et al. J Dig Dis. 2010 Jun;11(3):167-75. doi: 10.1111/j.1751-2980.2010.00432.x. J Dig Dis. 2010. PMID: 20579220 - Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients.
Feng Y, Sun B, Li X, Zhang L, Niu Y, Xiao C, Ning L, Fang Z, Wang Y, Zhang L, Cheng J, Zhang W, Hao X. Feng Y, et al. Breast Cancer Res Treat. 2007 Jul;103(3):319-29. doi: 10.1007/s10549-006-9385-7. Epub 2006 Nov 23. Breast Cancer Res Treat. 2007. PMID: 17123152 - HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review.
Carlsson J, Nordgren H, Sjöström J, Wester K, Villman K, Bengtsson NO, Ostenstad B, Lundqvist H, Blomqvist C. Carlsson J, et al. Br J Cancer. 2004 Jun 14;90(12):2344-8. doi: 10.1038/sj.bjc.6601881. Br J Cancer. 2004. PMID: 15150568 Free PMC article. Review. - Lymphatic metastasis in breast cancer: importance and new insights into cellular and molecular mechanisms.
Eccles S, Paon L, Sleeman J. Eccles S, et al. Clin Exp Metastasis. 2007;24(8):619-36. doi: 10.1007/s10585-007-9123-5. Epub 2007 Nov 6. Clin Exp Metastasis. 2007. PMID: 17985200 Review.
Cited by
- Desmocollin-1 is associated with pro-metastatic phenotype of luminal A breast cancer cells and is modulated by parthenolide.
Lapcik P, Sulc P, Janacova L, Jilkova K, Potesil D, Bouchalova P, Müller P, Bouchal P. Lapcik P, et al. Cell Mol Biol Lett. 2023 Aug 24;28(1):68. doi: 10.1186/s11658-023-00481-6. Cell Mol Biol Lett. 2023. PMID: 37620794 Free PMC article. - Horizontal Transfer of Malignant Traits and the Involvement of Extracellular Vesicles in Metastasis.
Arena GO, Forte S, Abdouh M, Vanier C, Corbeil D, Lorico A. Arena GO, et al. Cells. 2023 Jun 6;12(12):1566. doi: 10.3390/cells12121566. Cells. 2023. PMID: 37371036 Free PMC article. Review. - Identification of key genes in HER2-positive breast cancer with brain metastasis via bioinformatics methods.
Yang Z, Sun R, Qu G, Wang F, Yin Z, Zhang T, Wang P, Li S, Lin S. Yang Z, et al. Transl Cancer Res. 2023 May 31;12(5):1112-1127. doi: 10.21037/tcr-22-2715. Epub 2023 May 11. Transl Cancer Res. 2023. PMID: 37304544 Free PMC article. - Insulin-like growth factor binding protein 5: Diverse roles in cancer.
Waters JA, Urbano I, Robinson M, House CD. Waters JA, et al. Front Oncol. 2022 Nov 17;12:1052457. doi: 10.3389/fonc.2022.1052457. eCollection 2022. Front Oncol. 2022. PMID: 36465383 Free PMC article. Review. - Comprehensive analysis of gene expression profiles to identify differential prognostic factors of primary and metastatic breast cancer.
Albogami S. Albogami S. Saudi J Biol Sci. 2022 Jul;29(7):103318. doi: 10.1016/j.sjbs.2022.103318. Epub 2022 May 23. Saudi J Biol Sci. 2022. PMID: 35677896 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous